Senior CMC Advisor

Peter Nielsen has a background as biochemist and has more than 35 years of experience with pharmaceutical drug development in big pharma and biotech in leadership and specialist positions. He has broad and deep scientific understanding and very significant real life industry experience in bringing especially small molecules through the development process into commercial manufacturing.

Peter has a strong track record on fast and efficient CMC development of new medicines, specifically within oral drug delivery, from discovery to regulatory approval and transfer to commercial manufacturing.